US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Antibodies in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... the second wave in the lucrative field of therapeutic antibodies. There are today 527 companies plus partners developing 1187 antibody drugs in 2733 developmental projects in cancer. In addition, there are 5 suspended drugs and ...  |  read more...
USD 6,750
Immunotherapy in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... antibodies, vaccines, and immunostimulators in oncology drug development into one source. There are today 789 companies plus partners developing 1432 cancer immunotherapy drugs in 3604 developmental projects in cancer. In addition, there are 18 suspended ...  |  read more...
USD 11,025
Hematological Cancers Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... hematological cancer drugs in 2306 developmental projects in cancer. In addition, there are 10 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 299 drugs. Hematological Cancers Drug ...  |  read more...
USD 8,850
Apoptosis in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... cells. There are today 439 companies plus partners developing 566 apoptotic drugs in 2465 developmental projects in cancer. In addition, there are 12 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,750
Bladder Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... early, the 5 year survival rate is 94%. There are today 135 companies plus partners developing 143 drugs targeting bladder cancer in development. In addition, there are 3 suspended drugs and the accumulated number of ...  |  read more...
USD 4,485
Renal Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... cytokine therapy being less than 20% (RCC) in this patient cohort.The identification of biomarkers is set to revolutionize patient staging and prognosis by individualizing patient treatments and creating novel drug targets. There are today 236 ...  |  read more...
USD 6,750
Liver Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... over the last years amount to another 65 drugs. Liver Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 220 different ...  |  read more...
USD 4,485
Brain Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... diseases in the developed world. While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. There are today ...  |  read more...
USD 6,750
Peptides in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... of ceased drugs over the last years amount to another 146 drugs. Peptides In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are ...  |  read more...
USD 6,750
Head and Neck Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... number of ceased drugs over the last years amount to another 57 drugs. Head And Neck Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified ...  |  read more...
USD 6,750
Radiation Therapy in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 150 drugs. Radiation Therapy In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,750
Gene Therapy in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... accumulated number of ceased drugs over the last years amount to another 105 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. ...  |  read more...
USD 6,750
Cellular Therapy in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... accumulated number of ceased drugs over the last years amount to another 65 drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. ...  |  read more...
USD 4,485
Nucleic Acid Therapies in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... today 299 companies plus partners developing 363 nucleic acid therapy drugs in 740 developmental projects in cancer. In addition, there are 9 suspended drugs and the accumulated number of ceased drugs over the last years ...  |  read more...
USD 6,750
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... Alpha6Beta4 integrin pathway targeting drugs in 1683 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 203 drugs. Alpha6 ...  |  read more...
USD 6,750
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 254 drugs. Androgen Receptor Signaling Pathway In Oncology Drug Pipeline Update ...  |  read more...
USD 6,750
Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... several human malignancies include leukemias, gastrointestinal stromal tumors and mastocytomas. There are today 245 companies plus partners developing 338 Kit receptor pathway targeting drugs in 1442 developmental projects in cancer. In addition, there are 2 ...  |  read more...
USD 6,750
IL-2 Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... in 1525 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 179 drugs. Il-2 Signaling Pathway In Oncology Drug ...  |  read more...
USD 6,750
IL-3 Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... in 1158 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 127 drugs. Il-3 Signaling Pathway In Oncology Drug ...  |  read more...
USD 6,750
TSH Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... will give signaling to NF-kappa B, mitogen activated protein kinases, protein kinase C modules. There are today 222 companies plus partners developing 309 TSH pathway targeting drugs in 1283 developmental projects in cancer. In addition, ...  |  read more...
USD 6,750
FSH Signaling Pathway in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... signaling which continues further downstream. Activation of PKA leads to phosphorylation of transcription factors like cAMP response element binding protein(CREB) and brings about chromatin remodeling by phosphorylating histone H3. It also enhances the activity of ...  |  read more...
USD 6,750
Cancer Stem Cells Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 431 ...  |  read more...
USD 6,750
Calcium Signaling Pathway in Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... drug and the accumulated number of ceased drugs over the last years amount to another 124 drugs. Calcium Signaling Pathway In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on ...  |  read more...
USD 6,750
Cell Cycle Targeting in Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... drugs and the accumulated number of ceased drugs over the last years amount to another 123 drugs. Cell Cycle Targeting In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on ...  |  read more...
USD 6,750
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. There are today 514 companies plus partners developing 808 cytokine-cytokine receptor interaction interference ...  |  read more...
USD 6,750
6  7  8  9    11    13  14  15